Dexcom
The conference has been instigated and organised by ABCD. Sponsors* have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.
*A. Menarini Farmaceutica Internazionale ERL, AstraZeneca UK, Bayer Public Limited Company, Boehringer-Ingelheim and Lilly Alliance, Daiichi Sankyo UK, Medice UK Ltd, Novo Nordisk
Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering our community to take control of diabetes.
For more information on Dexcom G6 visit https://uk.provider.dexcom.com/
For more information on Dexcom G6 visit https://uk.provider.dexcom.com/
